[1]
“Persistent COVID-19 Infection In A B-Cell Depleted Patient With Successful Viral Clearance After Tixagevimab-Cilgavimab”, acmcr, vol. 8, no. 3, pp. 117–120, Jun. 2024, Accessed: Sep. 11, 2026. Available: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22945